Downstream activities of IL-22, such as maintaining mucosal epithelial integrity, alleviating metabolic dysfunctions, and reducing inflammation, may all contribute to the protective functions of IL-22 on NAFLD, obesity, and other metabolic syndromes [66]. This evidence concerns the gene IL22 and metabolic dysfunction-associated steatotic liver disease.